June 18, 2018 / 10:54 AM / 3 months ago

Investment firm CITIC Capital offers to buy China Biologic Products

June 18 (Reuters) - A unit of Chinese investment firm CITIC Capital Holdings Ltd has offered to buy U.S.-listed biotech firm China Biologic Products Holdings Inc.

The unit, CCRE, offered $110 in cash for each share of China Biologic it does not already own, valuing the Cayman Islands-headquartered company at $3.65 billion. (bit.ly/2leBZGo)

As of June 8, CCRE owned a 5.1 percent stake in China Biologic. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below